Analyst Ranking
Top 8%
#401 out of 5510 analysts
Average Return
+30.29%
Win Rate
43%19 out of 44
Risk vs Reward
Poor
Good

Yuan Zhi's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Fusion Pharmaceuticals IncFUSN
+554.97%$3.22$21.09
2023-10-03 -
2024-03-20
Strong Buy
Fusion Pharmaceuticals IncFUSN
+446.37%$3.86$21.09
2023-03-30 -
2024-03-20
Strong Buy
Tango Therapeutics IncTNGX
+197.25%$8.00$23.78
2025-11-18 -
2026-09-11
Strong Buy
Hyperfine IncHYPR
+166.67%$0.60$1.60
2025-05-15 -
2026-05-14
Strong Buy
Fusion Pharmaceuticals IncFUSN
+141.92%$2.29$5.54
2022-12-01 -
2023-11-30
Strong Buy

Yuan Zhi's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Nutex Health IncNUTX
1Strong Buy$325.00+62.31%Maintains
9 days ago
Hyperfine IncHYPR
3Strong Buy$1.60+102.53%Reiterates
a month ago
Mirion Technologies IncMIR
4Strong Buy$27.00+68.96%Maintains
a month ago
Lyell Immunopharma IncLYEL
1Strong Buy$44.00+267.89%Initiates Coverage On
2 months ago
Whitehawk Therapeutics IncWHWK
1Strong Buy$10.00+143.31%Initiates Coverage On
3 months ago
Strata Critical Medical IncSRTA
1Strong Buy$8.00+53.99%Initiates Coverage On
6 months ago
Perspective Therapeutics IncCATX
5Strong Buy$13.00+362.63%Maintains
6 months ago
Starling Oncology IncSTLN
2Strong Buy$8.00+29.66%Maintains
6 months ago
Radiopharm Theranostics LtdRADX
3Strong Buy$16.00+708.08%Reiterates
9 months ago
Radnet IncRDNT
2Strong Buy$87.00+15.25%Maintains
9 months ago
Tango Therapeutics IncTNGX
3Strong Buy$14.00-41.13%Maintains
10 months ago
Agenus IncAGEN
2Strong Buy$18.00N/AMaintains
2 years ago
Cryoport IncCYRX
4Strong Buy$15.00N/AUpgrades
2 years ago
Cytosorbents CorpCTSO
1Strong Buy$60.00N/AReiterates
2 years ago
Fusion Pharmaceuticals IncFUSN
4Hold$23.00N/ADowngrades
2 years ago
Azenta IncAZTA
3Strong Buy$79.00N/AMaintains
3 years ago
Ambrx Biopharma IncAMAM
2Hold$28.00N/ADowngrades
3 years ago
Actinium Pharmaceuticals IncATNM
4Strong Buy$16.00N/AMaintains
3 years ago
Iveric Bio IncISEE
3Hold$19.00N/AMaintains
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.